avoiding complications from biopsies and subsequent treatment are likely to decline screening (Tikkinen et al., 2018). Other men, including high-risk patients, may want to know and treat any potential prostate cancer. Conclusion The PSA test, although an unreliable test in the screening process of prostate cancer can be used to detect prostate disease and is not a valid test for all aging males. Asymptomatic men over fifty do not have to take the PSA; however, the practitioner should conduct a thorough interview, including family history, before making a joint decision. High-risk patients may opt-in or out of testing depending on their family history and weighing the pros and cons of having the knowledge. Since most prostate cancer is slow-growing many can assume that if it has not caused any symptoms that given the life expectancy of a male that no complications will arise before death.
5 References Khalid, A. N. (2015). Stepwise management of asthma. International Forum of Allergy & Rhinology , 5 (S1). doi : 10.1002/alr.21606 National Heart Lung and Blood Institute. (2007). Expert panel report 3 (EPR3 ): Guidelines for the diagnosis and management of asthma. Retrieved from Rosenthal, L. D., & Burchum , J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers . St. Louis, MO: Elsevier.
- Summer '15
- Prostate cancer, Prostate-specific antigen, Prostate-specific antigen test